Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma

por Valera, Vladimir A., Walter, Beatriz A., Linehan, W. Marston, Merino, Maria J.
Publicado 2011

Comprehensive microRNA Profiling of Prostate Cancer

por Walter, Beatriz A., Valera, Vladimir A., Pinto, Peter A., Merino, Maria J.
Publicado 2013

miR-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor Prognosis

por Walter, Beatriz A., Gómez-Macias, Gabriela, Valera, Vladimir A., Sobel, Mark, Merino, Maria J.
Publicado 2011

microRNA Expression Profiling in Young Prostate Cancer Patients

por Valera, Vladimir A., Parra-Medina, Rafael, Walter, Beatriz A., Pinto, Peter, Merino, Maria J
Publicado en J Cancer (2020)

Inactivation of the FLCN Tumor Suppressor Gene Induces TFE3 Transcriptional Activity by Increasing Its Nuclear Localization

por Hong, Seung-Beom, Oh, HyoungBin, Valera, Vladimir A., Baba, Masaya, Schmidt, Laura S., Linehan, W. Marston
Publicado 2010

Molecular Sub-Classification of Renal Epithelial Tumors Using Meta-Analysis of Gene Expression Microarrays

por Sanford, Thomas, Chung, Paul H., Reinish, Ariel, Valera, Vladimir, Srinivasan, Ramaprasad, Linehan, W. Marston, Bratslavsky, Gennady
Publicado 2011

Protein Expression Profiling in the Spectrum of Renal Cell Carcinomas

por Valera, Vladimir A, Li-Ning-T, Elsa, Walter, Beatriz A, Roberts, David D., Linehan, W M, Merino, Maria J
Publicado 2010

LDH-A Inhibition, a therapeutic strategy for treatment of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)

por Xie, Han, Valera, Vladimir A., Merino, Maria J., Amato, Angela M., Signoretti, Sabina, Linehan, W. M, Sukhatme, Vikas P., Seth, Pankaj
Publicado 2009

Identification and characterization of a novel folliculin-interacting protein FNIP2

por Hasumi, Hisashi, Baba, Masaya, Hong, Seung-Beom, Hasumi, Yukiko, Huang, Ying, Yao, Masahiro, Valera, Vladimir A., Linehan, W. Marston, Schmidt, Laura S.
Publicado 2008

IMMUNOHISTOCHEMICAL BASIS FOR ADJUVANT ANTI-ANGIOGENIC TARGETED THERAPY FOR RENAL CARCINOID: INITIAL CASE REPORT

por Finley, David S., Narula, Navneet, Valera, Vladimir A., Merino, Maria J., Fruehauf, John, Wu, Mark Li-cheng, Linehan, W. Marston, Clayman, Ralph V.
Publicado en Urol Oncol (2008)

Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-β signaling

por Hong, Seung-Beom, Oh, HyoungBin, Valera, Vladimir A, Stull, Jaime, Ngo, Duy-Tan, Baba, Masaya, Merino, Maria J, Linehan, W Marston, Schmidt, Laura S
Publicado 2010

“Super-active surveillance”: MRI ultrasound fusion biopsy and ablation for less invasive management of prostate cancer

por Bloom, Jonathan B., Gold, Samuel A., Hale, Graham R., Rayn, Kareem N., Sabarwal, Vikram K., Bakhutashvili, Ivane, Valera, Vladimir, Turkbey, Baris, Pinto, Peter A., Wood, Bradford J.
Publicado en Gland Surg (2018)

A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer

por Yang, Youfeng, Valera, Vladimir, Sourbier, Carol, Vocke, Cathy D., Wei, Minghui, Pike, Lisa, Huang, Ying, Merino, Maria A., Bratslavsky, Gennady, Wu, Min, Ricketts, Christopher J, Linehan, W. Marston
Publicado 2012

Adrenal Nodular Hyperplasia in Hereditary Leiomyomatosis and Renal Cell Cancer

por Shuch, Brian, Ricketts, Christopher J., Vocke, Cathy D., Valera, Vladimir A., Chen, Clara C., Gautam, Rabi, Gupta, Gopal N., Macias, Gabriela S. Gomez, Merino, Maria J., Bratslavsky, Gennady, Linehan, W Marston
Publicado en J Urol (2012)

Multiresolution Application of Artificial Intelligence in Digital Pathology for Prediction of Positive Lymph Nodes From Primary Tumors in Bladder Cancer

por Harmon, Stephanie A., Sanford, Thomas H., Brown, G. Thomas, Yang, Chris, Mehralivand, Sherif, Jacob, Joseph M., Valera, Vladimir A., Shih, Joanna H., Agarwal, Piyush K., Choyke, Peter L., Turkbey, Baris
Publicado en JCO Clin Cancer Inform (2020)

Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2

por Hasumi, Yukiko, Baba, Masaya, Ajima, Rieko, Hasumi, Hisashi, Valera, Vladimir A., Klein, Mara E., Haines, Diana C., Merino, Maria J., Hong, Seung-Beom, Yamaguchi, Terry P., Schmidt, Laura S., Linehan, W. Marston
Publicado 2009

Intrauterine growth retardation associated with precocious puberty and Sertoli cell hyperplasia

por Lodish, Maya B., Gartner, Lou Ann, Albini, Paul, Brodie, Angela, Meck, Jeanne M., Meloni-Ehrig, Aurelia M, Hill, Suvimol, Tsilou, Ekaterini, Carney, J. Aidan, Valera, Vladimir A., Walter, Beatriz A., Merino, Maria J., Stratakis, Constantine A.
Publicado 2010

Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer

por Rayn, Kareem N., Bloom, Jonathan B., Gold, Samuel A., Hale, Graham R., Baiocco, Joseph A., Mehralivand, Sherif, Czarniecki, Marcin, Sabarwal, Vikram K., Valera, Vladimir, Wood, Bradford J., Merino, Maria J., Choyke, Peter, Turkbey, Baris, Pinto, Peter A.
Publicado en J Urol (2018)

Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy

por Bloom, Jonathan B., Hale, Graham R., Gold, Samuel A., Rayn, Kareem N., Smith, Clayton, Mehralivand, Sherif, Czarniecki, Marcin, Valera, Vladimir, Wood, Bradford J., Merino, Maria J., Choyke, Peter L., Parnes, Howard L., Turkbey, Baris, Pinto, Peter A.
Publicado en J Urol (2019)

UOK 262: Fumarate Hydratase (-/-) Hereditary Leiomyomatosis Renal Cell Carcinoma: In Vitro and In Vivo Model of an Aberrant Energy Metabolic Pathway in Human Cancer

por Yang, Youfeng, Valera, Vladimir A., Padilla-Nash, Hesed M., Sourbier, Carole, Vocke, Cathy D., Vira, Manish A., Abu-Asab, Mones S., Bratslavsky, Gennady, Tsokos, Maria, Merino, Maria J., Pinto, Peter A., Srinivasan, Ramaprasad, Ried, Thomas, Neckers, Len, Linehan, W. Marston
Publicado 2010